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Abstract
In this work we prove occurrence of a super-critical Hopf bifur-
cation in a model of white blood cell formation structured by three
maturation stages. We provide an explicit analytical expression for
the bifurcation point depending on model parameters. The Hopf bi-
furcation is a unique feature of the multi-compartment structure as it
does not exist in the corresponding two-compartment model. It ap-
pears for a parameter set different from the parameters identified for
healthy hematopoiesis and requires changes in at least two cell proper-
ties. Model analysis allows identifying a range of biologically plausible
parameter sets that can explain persistent oscillations of white blood
cell counts observed in some hematopoietic diseases. Relating the
identified parameter sets to recent experimental and clinical findings
provides insights into the pathological mechanisms leading to oscillat-
ing blood cell counts.
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1 Introduction
This work is devoted to the study of Hopf bifurcations and emergence of
oscillatory dynamics in a multi-compartmental model of healthy blood cell
production (hematopoiesis). The model describes a multi-stage blood cell
production process based on self-renewal and differentiation of stem and pro-
genitor cells, which is needed for regeneration of mature white blood cells.
Each maturation stage is treated as a homogeneous compartment and its time
evolution is described by an ordinary differential equation with coefficients
controlled by a nonlinear feedback signal that depends on the count of ma-
ture cells. The model was introduced in ref. [47] and then has been applied to
study blood cell recovery after bone marrow transplantation [59,60] and ex-
tended to model evolution and response to therapy of hematological diseases
such as acute leukemias [57, 58, 61, 63] and myelodysplastic syndromes [68].
Although mathematical understanding of the underlying equations proved
to be useful for model applications and interpretation in context of the pa-
tients’ data [6, 57], rigorous analysis of the underlying equations has been
established only in the case of a two-compartment maturation structure in
ref. [20]. In this work, we close the gap and provide analysis of a system in-
volving an intermediate differentiation stage given by a three-compartment
structure. While in case of the two-compartment model, the positive equi-
librium is globally stable whenever it exists [20], our analysis shows that
increasing the number of compartments may lead to the loss of stability of
the positive equilibrium due to a super-critical Hopf bifurcation. This find-
ing is of biological relevance, since it shows that the number of maturation
stages may impact the system dynamics.
Periodic oscillations in a model with non-linear feedback mechanisms but
without explicit delays have not been studied in the context of hematopoietic
system so far. Our model shows that we can have cycling hematopoiesis as
inherent property of the multistep maturation process, however, arising far
away from the parameter regime corresponding to the healthy system. Pe-
riodic oscillations of blood cell counts are a rare but intriguing phenomenon
that can be observed in humans and animals [11, 13, 23]. Cyclic neutrope-
nia is the most frequent disease with oscillating blood cell counts. In cyclic
neutropenia patients’ neutrophil counts show periodic oscillations with max-
ima that are significantly below the neutrophil counts of healthy individuals.
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Since neutrophils are responsible for immune defence, patients repeatedly
suffer from infections [15]. The disease can be cured by transplantation of
healthy bone marrow [14, 53]. Similarly, accidental transplantation of bone
marrow from a patient with cyclic neutropenia transfers the disorder to a
previously unaffected host as has been shown in ref. [36]. A mechanistic
understanding of the disease, therefore, requires quantitative insights into
blood cell formation and its regulations.
Cyclic neutropenia has been extensively studied using mathematical mod-
els. One hypothesis derived from mathematical models is that oscillations
are caused by increased apoptosis /reduced proliferation of neutrophil precur-
sors [3,41] combined with a reduced entry of stem cells into the proliferative
phase [10]. An alternative mechanism could be an increase of the death rates
of stem cells [41,44]. Other model-derived hypotheses for the origin of cyclic
neutropenia include reduced maturation speed [70] or dysfunction of feedback
mechanisms [67]. Experimental studies suggest abnormal responsiveness of
cells to growth factors [24, 72] or increased apoptosis of progenitor cells [22]
as possible reasons for the origin of periodic oscillations. One common fea-
ture of most models of cyclic neutropenia is that they include constant or
distributed delays. Intuitively, a system with feedbacks the effects of which
occur with a delay, can be supposed to oscillate if the feedback loop gain
is large enough. However, whether oscillations indeed appear, depends on
configuration of feedbacks. In ref. [16] it has been shown that a reduction of
progenitor cell’s self-renewal is sufficient to explain oscillatory dynamics in a
model with linear feedback regulation and without delays. However, a system
of linear compartments effectively constitutes a delay distributed according
to a convolution of negative exponential functions, i.e. non-central gamma
type, [30](Section 17.8.7). Other mathematical modeling works studying
cyclic neutropenia include [21, 27, 31, 35]. Different modeling approaches are
reviewed in [9, 26].
The paper is organized as follows. In Section 2 we present a derivation
of the considered model and its biological justification. In Section 3 we
provide analytical results, including uniform boundedness of solutions and
linear stability analysis. We provide criteria for the occurrence of a Hopf
bifurcation and illustrate them by model simulations. In Section 4 we study
systematically for which subsets of the biologically relevant parameter space
Hopf bifurcations occur and we relate our findings to experimental results.
Section 5 concludes with a short summary and a discussion of the obtained
results.
3
2 Model motivation and formulation
Blood cells are continuously produced during the life of higher metazoans.
This task is fulfilled by the hematopoietic (blood forming) system which is
located in the bone marrow [55]. Hematopoietic stem cells (HSC) give rise
to progenitor cells which subsequently produce mature cells [55]. Due to its
vital importance hematopoiesis is a tightly regulated process. Complex non-
linear feedback mechanisms allow the organisms to adapt to environmental
conditions and to efficiently respond to perturbations such as blood loss or
infection [48]. Key processes during hematopoiesis are cell proliferation, self-
renewal and differentiation. Proliferation denotes the division of one parent
cell into two progeny. If progeny are of the same cell type as the parent, e.g.,
a progeny of a stem cell is again a stem cell, this process is referred to as
self-renewal. The alternative scenario, where progeny are of a more mature
cell type compared to their parent cell is referred to as differentiation [64,65].
In this work, we study for which configurations of proliferation and self-
renewal parameters periodic oscillations of blood cell counts can occur. We
focus on a three-compartment version of the model describing dynamics of
stem cells, progenitor cells and mature cells. Dynamics of each cell population
is described by an ordinary differential equation. Denoting the number of
cells per kg of body weight at time t as ui(t), where i = 1 corresponds to
stem cells, i = 2 to progenitor cells and i = 3 to mature white cells, each cell
type is characterized by the following parameters:
• Proliferation rate pi, describing the frequency of cell divisions per unit
of time. In accordance with biology we assume that mature cells do
not divide [29].
• Fraction of self-renewal ai, describing the fraction of progeny cells orig-
inating from division and returning to the compartment of their parent
cell.
• Death rate di, describing the fraction of cells dying per unit of time.
For simplicity, we assume that immature cells (i = 1, 2) do not die and
that mature cells die at constant rates. This is a good approximation
of reality [29, 60],
White blood cell production is regulated by negative feedback signals,
such as G-CSF [40, 48]. Since signal dynamics take place on a faster time
scale compared to cell divisions, a quasi-steady state approximation can be
used to describe the signal concentration as a function of white blood cell
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counts [46,47,62].
s(t) =
1
1 + ku3(t)
,
where k > 0, see [47] for details. Rigorous proof of the corresponding quasi-
steady state model reduction is presented in ref. [46].
Following the previous work [47,59,60], we assume feedback inhibition of
the fraction of self-renewal by mature cells, i.e. ai(t) = ais(t).
The flux to division of healthy cells in compartment i at time t equals
piui(t). During division, a parent cell is replaced by two progeny cells. The
outflux from mitosis at time t, therefore, equals 2piui(t), of which the fraction
2ai(t)piui(t) stays in compartment i (referred to as self-renewal). The fraction
2(1− ai(t))piui(t) proceeds to maturation stage i+ 1 (process referred to as
differentiation). Taking into account that mature cells do not divide and
that the parent cell disappears as it gives rise to its progeny, we obtain the
following system of differential equations
du1
dt
=
(
2
a1
1 + k u3
− 1
)
p1 u1 (M1)
du2
dt
=
(
2
a2
1 + k u3
− 1
)
p2 u2 + 2
(
1− a1
1 + k u3
)
p1 u1 (M2)
du3
dt
= 2
(
1− a2
1 + k u3
)
p2 u2 − d3 u3, (M3)
where p1, p2 > 0, d3 > 0 and k > 0. The initial conditions fulfill u1(0) > 0,
u2(0) ≥ 0, u3(0) ≥ 0. A schematic of the model is depicted in Figure 1.
In order to simplify our calculations, we finally rewrite the model equa-
tions in dimensionless terms using the reparametrizations t˜ := p1 t, p˜2 :=
p2
p1
,
d˜3 :=
d3
p1
, and u˜i
(
t˜
)
:= ui
(
t˜
p1
)
for i = 1, 2, 3:
du˜1
dt
=
(
2
a1
1 + k u˜3
− 1
)
u˜1 (M1*)
du˜2
dt
=
(
2
a2
1 + k u˜3
− 1
)
p˜2 u˜2 + 2
(
1− a1
1 + k u˜3
)
u˜1 (M2*)
du˜3
dt
= 2
(
1− a2
1 + k u˜3
)
p˜2 u˜2 − d˜3 u˜3 (M3*)
The parameter ranges and initial conditions remain unchanged. For conve-
nience, we drop the ˜-symbol in the remainder of this paper.
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Figure 1: Scheme of the model. p1,2 denote the proliferation rates, a1,2 the
fractions of self-renewal, d3 the death rate, and s the feedback-signal.
3 Model analysis
In this section we show uniform boundedness of solutions (Section 3.1), pro-
vide conditions for existence of non-negative steady states (Section 3.2) and
linearized stability analysis (Section 3.3), and prove occurrence of Hopf bi-
furcation (Section 3.4).
3.1 Uniform boundedness of solutions
Theorem 1. Solutions of (M1)-(M3) with positive initial values remain in
the first octant and for sufficiently large times t even in a compact subset C
which does not depend on the initial values.
Proof. The proof follows the lines of the proof in ref. [6], adjusted to the three-
compartment structure of the model. We consider the rescaled system (M1*)-
(M3*) and define C as the cuboid bounded by the planes {(u1, u2, u3) ∈ R3 |
ui = 0} and {(u1, u2, u3) ∈ R3 | ui = Ci} for i = 1, 2, 3. Obviously, the
orbits of solutions with nonnegative initial values remain in the first octant.
To show uniform boundedness from above, we compute equations for the
fractions v1 :=
u1
u2
and v2 :=
u2
u3
that lead to the following estimates,
dv1
dt
< [1 + p2 − 2 (1− a1) v1] v1 < 0 for v1 ≥ 1 + p2
2 (1− a1) =: B1
dv2
dt
< [p2 + d3 + 2B1 − 2 (1− a2) v2] v2 < 0 for v2 ≥ p2 + d3 + 2B1
2 (1− a2) =: B2,
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for all u3 ≥ 0. Taking Mi := max{Bi, vi(0)}, we conclude u2 ≥ 1M1 u1 and
u3 ≥ 1M2u2 ≥ u1 1M2M1 . With these relations we obtain
du1
dt
≤
(
2
a1
1 + k
M2M1
u1
− 1
)
u1 < 0, for u1 >
M2M1
k
(2 a1 − 1) =: K1
and
du2
dt
≤
(
2
a2
1 + k
M2
u2
− 1
)
p2 u2 + 2K1 < 0
for u2 > max
{
4 a2 − 1
k
M2,
4
p2
K1
}
=: K2
as well as
du3
dt
≤ 2 p2K2 − d3 u3 < 0
for u3 >
2 p2K2
d3
=: K3.
Taking Ci = max{Ki, ui(0)}, we conclude about invariance of the set C.
3.2 Existence of steady states
Existence and uniqueness of steady states has been systematically studied in
ref. [62]. The following proposition summarizes the results.
Proposition 2. 1. The trivial steady state E0 = (u¯
0
1, u¯
0
2, u¯
0
3)
T
= (0, 0, 0)T
of (M1) - (M3) exists for all parameter values.
2. There exists a semi-trivial steady state E1 = (0, u¯
1
2, u¯
1
3)
T
of (M1) - (M3)
with positive components u¯12, u¯
1
3 given by
E1 =
(
0,
d3
p2
u¯13,
2 a2 − 1
k
)T
if and only if
a2 >
1
2
.
3. There exists a strictly positive steady state E2 = (u¯
2
1, u¯
2
2, u¯
2
3)
T
of (M1)
- (M3) given by
E2 =
(1− a2
a1
)
p2
p1
u¯22,
d3(
2− a2
a1
)
p2
u¯23,
2 a1 − 1
k
T
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if and only if
a1 >
1
2
and a2 < a1.
Let us remark that for appropriate values of d3, p2, and k the steady
state E2 can be any point in R3+. We have E2 = (u¯1, u¯2, u¯3) if
k =
2 a1 − 1
u¯3
, d3 =
2− a2
a1
1− a2
a1
u¯1
u¯3
p1, p2 =
d3
2− a2
a1
u¯3
u¯2
.
3.3 Linear asymptotic stability
In Proposition 3 we summarize the linear asymptotic stability of the steady
states E0 and E1. In Theorem 4 we study the linear asymptotic stability of
E2 using the Routh-Hurwitz Criterion.
Proposition 3. (i) The steady state E0 = (0, 0, 0)
T is locally asymptoti-
cally stable if max{a1, a2} < 12 and unstable if max{a1, a2} > 12 .
(ii) The steady state E1 =
(
0, d3
p2
2 a2−1
k
, 2 a2−1
k
)T
is locally asymptotically
stable if a1 < a2 and unstable if a1 > a2.
Proof. The Jacobian of system (M1*)-(M3*) at the steady state (u¯i1, u¯
i
2, u¯
i
3)is
given by
J
(
u¯i1, u¯
i
2, u¯
i
3
)
=
2 a1
1+k u¯i3
− 1 0 −2 a1 k 1
(1+k u¯i3)
2 u¯i1
2
(
1− a1
1+k u¯i3
) (
2 a2
1+k u¯i3
− 1
)
p2 −2 p2 a2 k 1
(1+k u¯i3)
2 u¯i2 + 2 a1 k
1
(1+k u¯i3)
2 u¯i1
0 2
(
1− a2
1+k u¯i3
)
p2 2 p2 a2 k
1
(1+k u¯i3)
2 u¯i2 − d3
 .
(i) Consider the Jacobian matrix at E0
J (0, 0, 0) =
 2 a1 − 1 0 02 (1− a1) (2 a2 − 1) p2 0
0 2 (1− a2) p2 −d3
 .
As J (0, 0, 0) is a lower triangular matrix, we obtain the eigenvalues
λ01 = 2 a1 − 1
λ02 = (2 a2 − 1) p2
λ03 = −d3,
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which implies (i).
(ii) Consider the Jacobian matrix at E1
J
(
u¯11, u¯
1
2, u¯
1
3
)
=

a1
a2
− 1 0 0
2− a1
a2
0 −
(
1− 1
2 a2
)
d3
0 p2 − 12 a2 d3
 .
We recall that for existence of E1 it has to hold a2 > 1/2. We obtain the
characteristic equation(
λ− a1
a2
+ 1
) [
λ
(
λ+
1
2 a2
d3
)
+
(
1− 1
2 a2
)
d3 p2
]
= 0
and thus the eigenvalues
λ11 =
a1
a2
− 1
λ12 = −
1
4 a2
d3 +
√(
1
4 a2
d3
)2
−
(
1− 1
2 a2
)
d3 p2
λ13 = −
1
4 a2
d3 −
√(
1
4 a2
d3
)2
−
(
1− 1
2 a2
)
d3 p2︸ ︷︷ ︸
< 1
4 a2
d3 or imaginary, since a2 > 0.5
As λ12 and λ
1
3 have always negative real parts, the only condition that needs
to hold for E1 to be locally asymptotically stable is a1 < a2. If a1 > a2, E1
is unstable.
For E2, we will show local asymptotic stability using the Routh-Hurwitz-
Criterion.
Using the expression for E2 from Proposition 2 we can prove the following
Theorem 4. The positive steady state E2 of system (M1) - (M3) is locally
asymptotically stable if
p2 >
1
1− a2
a1
[
1
γ (a1, a2)
− β (a1, a2) d3
p1
]
p1. (1)
E2 unstable if
p2 <
1
1− a2
a1
[
1
γ (a1, a2)
− β (a1, a2) d3
p1
]
p1, (2)
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where
β (a1, a2) = 1− a2
a1
(
1− 1
2 a1
)
1
2− a2
a1
γ (a1, a2) =
1
2 a1
1
1− 1
2 a1
+
a2
a1
1(
2− a2
a1
) (
1− a2
a1
) .
Proof. We perform calculations for the transformed system (M1*)-(M3*).
Consider the Jacobian matrix at E2, i.e.
J
(
u¯21, u¯
2
2, u¯
2
3
)
=

0 0 −
(
1− 1
2 a1
) (
1− a2
a1
)
1
2−a2
a1
d3
1 −
(
1− a2
a1
)
p2
(
1− 1
2 a1
) (
1− 2 a2
a1
)
1
2−a2
a1
d3
0
(
2− a2
a1
)
p2
(
a2
a1
(
1− 1
2 a1
)
1
2−a2
a1
− 1
)
d3
 .
We obtain the characteristic equation
0 = λ3 +
[(
1− a2
a1
)
p2 +
(
1− a2
a1
(
1− 1
2 a1
)
1
2− a2
a1
)
d3
]
︸ ︷︷ ︸
=:b1
λ2
+
[(
1− a2
a1
) (
1− a2
a1
(
1− 1
2 a1
)
1
2− a2
a1
)
−
(
1− 1
2 a1
) (
1− 2 a2
a1
)]
d3 p2︸ ︷︷ ︸
=:b2
λ
+
(
1− 1
2 a1
) (
1− a2
a1
)
d3 p2︸ ︷︷ ︸
=:b3
.
We observe that under positivity conditions for E2 (a1 > a2 and a1 >
1
2
)
the relations b1 > 0 and b3 > 0 hold true: b3 is a product with positive
factors only and therefore positive itself. The expression b1 can be written
as b1 =
(
1− a2
a1
)
p2 + (1− P ) d3 where P is a product consisting of factors
that are in (0, 1) under positivity conditions. Thus, 1 − P is positive and,
therefore, b1 is, as a sum of two positive summands, positive as well.
We distinguish between the following parameter configurations. Details
can be found in the book by Gantmacher [17].
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b1 b2 − b3 > 0 ⇔ λ1, λ2, λ3 have negative real parts.
b1 b2 − b3 = 0 ⇔ There is one eigenvalue with negative real part and a couple of
complex conjugated eigenvalues with zero real parts.
b1 b2 − b3 < 0 ⇔ There is one eigenvalue with negative and two with positive real parts.
It remains to determine conditions so that the relations b1 b2 − b3 > 0
and b1 b2 − b3 < 0 respectively are satisfied, to complete the proof. Using
β (a1, a2) and γ (a1, a2) as defined in the theorem, we can rearrange b1 b2− b3
as follows. Further details on how to proceed can be found in the appendix
A.
b1 b2 − b3 (3)
=
(
1− 1
2 a1
) (
1− a2
a1
) ([(
1− a2
a1
)
p2 + β (a1, a2) d3
]
· γ (a1, a2)− 1
)
d3 p2.
As the factors
(
1− 1
2 a1
)
and
(
1− a2
a1
)
are positive under positivity con-
ditions for E2 and d3 and p2 are positive anyway, it suffices to find conditions
which ensure that the remaining factor is of positive sign. We find
0 <
[(
1− a2
a1
)
p2 + β (a1, a2) d3
]
· γ (a1, a2)− 1
⇔ p2 > 1
1− a2
a1
[
1
γ (a1, a2)
− β (a1, a2) d3
]
(4)
Thus, the eigenvalues of the Jacobian matrix at E2 have negative real parts
if and only if relation (4) holds. This implies local asymptotic stability. In
analogy there exist eigenvalues with positive real parts if and only if b1 b2 −
b3 < 0. Transforming back to the parameters of system (M1)-(M3) completes
the proof of this theorem.
Finally, we will see that the parameter range where E2 exists and is
unstable is bounded:
Proposition 5. For p1 = 1 the set
A =
{
(a1, a2, d3, p2) ∈ (0, 1)2 × R2+ | a1 >
1
2
, a1 > a2, E2 is unstable
}
,
i.e. the parameter range where E2 exists, is positive and is unstable, is a
bounded subset of the parameter space.
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Proof. First, we note that for all (a1, a2, d3, p2) ∈ A it holds that
p2 ≤ 1
1− a2
a1
[
1
γ (a1, a2)
− β (a1, a2) d3
]
and thus
A ⊆
⋃
a1∈( 12 ,1),a2∈(0,a1)
{a1} × {a2} × Aa1,a2 ,
where
Aa1,a2 = {(d3, p2) ∈ R2+ | p2 ≤
1
1− a2
a1
[
1
γ (a1, a2)
− β (a1, a2) d3
]
}.
As the range of a1 and a2 is bounded anyway, it suffices to show that the sets
Aa1,a2 are uniformly bounded. To this end, we observe that for fixed a1 and
a2 the boundary of each Aa1,a2 consists of the part of the graph of the linear
equation
p2 =
1
1− a2
a1
[
1
γ (a1, a2)
− β (a1, a2) d3
]
lying in the first quadrant and its axis intercepts (see Figure 2). We will show
Figure 2: The set Aa1,a2 for a1 = 0.75 and a2 = 0.55. α = 1− a2a1
that the intercepts of the d3- and the p2-axis
1
β(a1,a2) γ(a1,a2)
and 1
(1−a2
a1
)·γ(a1,a2)
respectively are uniformly bounded. For p2 ∈ Aa1,a2 for all a1, a2 ∈ (0, 1) it
holds:
1
p2
≥ γ (a1, a2)
(
1− a2
a1
)
>
1
2
[
1− a2
a1
1− 1
2 a1
+
a2
a1
]
=
1
2
[
1 +
1
2 a1
1− a2
a1
1− 1
2 a1
]
>
1
2
.
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This is equivalent to p2 < 2 for all a1, a2 ∈ (0, 1). Furthermore, we note that
γ (a1, a2) β (a1, a2) > γ (a1, a2)
(
1− a2
a1
)
>
1
2
and thus, we also have for all d3 ∈ Aa1,a2 d3 ≤ 1β(a1,a2) γ(a1,a2) < 2 ∀a1, a2 ∈
(0, 1). This means that the set Aa1,a2 are uniformly bounded and therefore,
the set A consisting of all parameters for which E2 is unstable is bounded.
Table 1 summarizes existence and local asymptotic stability of the equi-
libria E0 to E2.
a1 > a2 a1 < a2
a1 <
1
2
, a2 <
1
2
E0: stable
E1 : @
E2 : @
E0: stable
E1 : @
E2 : @
a1 <
1
2
, a2 >
1
2
E0: unstable
E1: stable
E2 : @
a1 >
1
2
, a2 <
1
2
E0: unstable
E1 : @
E2: exists
a1 >
1
2
, a2 >
1
2
E0: unstable
E1: unstable
E2: exists
E0: unstable
E1: stable
E2 : @
Table 1: Summary of existence and stability conditions for the steady states
depending on the parameter values of a1 and a2. ”stable” refers to local
asymptotic stability.
Corollary 6. The steady state E2 exists and is locally asymptotically stable
if and only if
a1 >
1
2
a1 > a2
p2 >
1
1− a2
a1
[
1
γ (a1, a2)
− β (a1, a2) d3
p1
]
p1.
In this case all other non-negative steady states are unstable.
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3.4 Hopf bifurcation
In this section, we will further investigate the change of the dynamical be-
havior when p2 passes through
1
1−a2
a1
[
1
γ(a1,a2)
− β (a1, a2) d3p1
]
p1. We note
that this is only possible if 1
1−a2
a1
[
1
γ(a1,a2)
− β (a1, a2) d3p1
]
p1 > 0 holds, i.e.
for d3 < d
max
3 :=
p1
β(a1,a2) γ(a1,a2)
.
Theorem 7. Let dmax3 :=
p1
β(a1,a2) γ(a1,a2)
and d3 < d
max
3 . Then the steady
state E2 undergoes a Hopf bifurcation with bifurcation point p2 = p
∗
2 :=
1
1−a2
a1
[
1
γ(a1,a2)
− β (a1, a2) d3p1
]
p1, i.e. the Jacobian matrix J at the positive
steady state E2 has two eigenvalues λ1, λ2 for which the following relations
hold
λ1,2(p2) = µ(p2)± ω(p2), ω(p∗2) 6= 0, µ(p∗2) = 0,
d
d p2
µ(p∗2) 6= 0.
Proof. We consider the system (M1*)-(M3*). We recall that existence of E2
requires a1 > 0.5 and a2 < a1. Let P (x) = x
3 + b1 x
2 + b2 x+ b3 be the char-
acteristic polynomial of J . From the proof of Theorem 4 we know that J has
two purely imaginary eigenvalues unequal to zero if and only if b1 b2− b3 = 0,
i.e., p2 = p
∗
2. Thus, for λ1,2(p2) := µ(p2)±ω(p2) it holds µ(p∗2) = 0, ω(p∗2) 6= 0.
It remains to show that µ′(p∗2) 6= 0.
Let us rewrite the characteristic polynomial P (x) as
P (x) = (x− λ1) (x− λ2) (x− λ3), where λ3 denotes the third eigenvalue.
We can verify easily that the relation b1 b2 − b3 = −P (λ1 + λ2 + λ3) holds.
We will obtain an expression for µ′(p∗2) by computing the derivatives of both
sides of this equation with respect to p2.
d
dp2
P (λ1 (p2) + λ2 (p2) + λ3 (p2))
∣∣∣∣
p2=p∗2
=
d
dp2
[(µ (p2)− i ω (p2) + λ3 (p2)) (µ (p2) + i ω (p2) + λ3 (p2)) · 2µ (p2)]
∣∣∣∣
p2=p∗2
=2µ′ (p∗2)
(
λ23 (p
∗
2) + ω
2 (p∗2)
)
Now we calculate the derivative with respect to p2 of b1 b2 − b3:
d
dp2
[−b1 b2 + b3]
∣∣∣∣
p2=p∗2
=−
(
1− 1
2 a1
) (
1− a2
a1
)2
d3 γ (a1, a2) d3p
∗
2
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By equating both expressions for the derivative we obtain:
µ′ (p∗2) = −
(
1− 1
2 a1
) (
1− a2
a1
)2
d3 γ (a1, a2) d3p
∗
2
2 (λ23 (p
∗
2) + ω
2 (p∗2))
< 0
for p∗2 > 0, since a1 > a2 implies γ(a1, a2) > 0. We note that d3 < d
max
3
implies p∗2 > 0. since d3 < d
max
3 . This completes the proof.
Remark 8. We note that the bifurcation point does not depend on k.
Remark 9. It holds b1(p2) = −(λ1(p2)+λ2(p2)+λ3(p2)) which equals −λ3(p∗2)
if p2 = p
∗
2. As we noted in the preceding proof, we have b1 = −λ3(p∗2) and
therefore, we can explicitly compute the eigenvalues of the Jacobian matrix
for the case p=p
∗
2.
λ3(p
∗
2) = −
1
γ (a1, a2)
.
Similarly, b3(p2) = −λ1(p2)λ2(p2)λ3(p2) and b3(p∗2) = −λ3 (p∗2)ω2 (p∗2), which
implies
ω (p∗2) =
√
b3(p∗2)γ(a1, a2)
=
√(
1
γ (a1, a2)
− β (a1, a2) d3
)
γ (a1, a2)
(
1− 1
2 a1
)
d3
We note that the third eigenvalue λ3 has a negative real part, since γ(a1, a2) >
0. Consequently, for p2 = p
∗
2 the orbits of the system exponentially approach
a center manifold. On the center manifold, the orbits look essentially like the
ones of the Hopf normal form as shown in ref. [38].
Figure 3 provides a numerical example for the super-critical Hopf bifur-
cation.
4 Biological implications
In this section we apply the mathematical results to gain insights into the
origin of oscillating blood cell counts. We use our model to systematically
study which parameters have to deviate from their physiological values to
obtain persistent oscillations.
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(A)
(B)
p2=0.4725
p2=0.3544
Figure 3: (A) Phase portrait for p2 > p
∗
2. The solution converges to the
positive equilibrium. Initial condition: u1(0) = 0.1766 · 107, u2(0) = 1.3082 ·
107, u3(0) = 5.9429 · 107. (B) Phase portrait for p2 < p∗2. Existence of a
stable limit cycle. Initial conditions: u1(0) = 0.2717·107, u2(0) = 2.6836·107,
u3(0) = 9.1429 · 107 and u1(0) = 0.1766 · 107, u2(0) = 1.7443 · 107, u3(0) =
5.9429 ·107. Initial conditions are marked by crosses, the positive equilibrium
is marked by ”*”. Parameters: a1 = 0.7, a2 = 0.5, p1 = 1, d3 = 0.1337,
ks = 8.75 · 10−9. The Hopf bifurcation occurs at p∗2 = 0.3937.
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Figure 4: Overlay of patient data and example simulations: Modle sim-
ulations qualitatively reproduce neutrophil dynamics in cyclic neutropenia.
Patient data taken from ref. [13], Fig. 2A. Parameters: (A) a1 = 0.85, p1 = 1,
a2 = 0.841/day, p2 = 0.4/day, d1 = 0, d2 = 0.5592/day, d3 = 0.36765/day,
k = 3.5 · 10−8. (B) a1 = 0.85, p1 = 0.9293, a2 = 0.841/day, p2 = 0.0150/day,
d1 = 0, d2 = 0.2541/day, d3 = 2.3/day, k = 3.2 · 10−8.
4.1 Numerical studies
Parameters of model (M1)-(M3) have been obtained using a combination of
data from literature and patient data. It has been shown that the calibrated
model can reproduce blood cell dynamics after bone marrow transplantation
and during acute leukemia [57–61]. The parameters have been estimated as
follows [58]:
a1 = 0.850, p1 = 0.1/day, a2 = 0.841, p2 = 0.4/day, d1 = 0.0, d2 = 0.0,
d3 = 2.7/day, k = 1.75 · 10−9.
In the following we refer to these parameters as reference values. To
systematically check whether variation of one of these parameters can lead to
a Hopf bifurcation, we search, where in the parameter space p2 passes through
the bifurcation point p∗2. Biologically plausible intervals for the respective
parameters are:
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Constellation 2 Constellation 3Constellation 1
Constellation 5 Constellation 6Constellation 4
Constellation 8 Constellation 9Constellation 7
Figure 5: Parameter regions where oscillating solutions exist. Explicit ex-
amples for parameter values are provided in Appendix B. Parameter values
are presented as percentages of the healthy parameters: aH1 - self-renewal of
healthy stem cells, aH1 - self-renewal of healthy progenitor cells, p
H
1 - prolifer-
ation rate of healthy stem cells, pH2 - proliferation rate of healthy progenitor
cells, dH3 - clearance rate of healthy granulocytes. Since in the healthy system
immature cells do not die (dH1 = d
H
2 = 0), d1 and d2 are given as percentages
of dH3 .
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a1 ∈ (0.5, 1)
p1 ∈ (0/day, 1/day)
a2 ∈ (0, 1)
p2 ∈ (0/day, 1/day)
d1 ∈ (0/day, 3/day)
d2 ∈ (0/day, 3/day)
d3 ∈ (0.1/day, 3/day)
These ranges are motivated as follows. The self-renewal fractions a1 and
a2 correspond to the probabilities that a progeny cell belongs to the same
maturation stage as its parent cell, therefore they assume values between
zero and one. If a1 ≤ 0.5, the stem cell population declines over time [62],
which contradicts biological observations [62,64]. For this reason we assume
a1 > 0.5. A proliferation rate of 1/day corresponds to more than one cell
division per day, which is the biological upper limit required for genome du-
plication [50]. The value of d3 corresponds to a neurophils half life between 5
hours and 7 days what is in agreement with measurements in humans [7,54].
Of note biological studies suggest, that in cyclic neutropenia neutrophils half
life does not significantly differ from reference values [23]. As neutrophils are
considered as one of the cell types with shortest half life, we assume that 5
hours is a reasonable lower bound also for the half life of immature cells [29].
For our numerical studies we subdivide the given intervals in 100 equidistant
points.
There is biological evidence that oscillating blood cell counts may be re-
lated to death of immature cells [22]. For this reason we extend our numerical
analysis to the case where stem and progenitor cell death rates, denoted as
d1 and d2, can be positive. In this case we obtain the following expressions
for b1, b2 and b3.
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b1 = d2 −
(
a2
a1
d1 + p1
p1
− 1
)
p2 + d3
1 +
((
1− 1
2a1
)
p1 − d12a1
)
a2
a1
d1+p1
p1(
a2
a1
d1+p1
p1
− 2
)
p1

b2 = +d3
((
1− 1
2a1
)
p1 − d1
2a1
)
d1 + p1
p1
a2p2
a1p1
+
p2
(
a2
a1
d1+p1
p1
− 1
)
− d2
p1 − d1

−
(
p2
(
a2
a1
d1 + p1
p1
− 1
)
− d2
)
d3
1 +
((
1− 1
2a1
)
p1 − d12a1
)
a2
a1
d1+p1
p1(
a2
a1
d1+p1
p1
− 2
)
p1

b3 = −
(
p2
(
a2
a1
d1 + p1
p1
− 1
)
− d2
)((
1− 1
2a1
)
p1 − d1
2a1
)
d1 + p1
p1
d3
We numerically check at which locations of the parameter space b1b2− b3
changes its sign from positive to negative. In the considered parameter space
b1 and b3 are positive.
Remark 10. Global boundedness of solutions also holds for the extended
model with positive d1 and d2. The proof works analogously to the proof of
Theorem 1 with B1 :=
1+p2+d2−d1
2(1−a1) and B2 :=
2B1+d3+p2
2(1−a2) . The expression for
the unique strictly positive steady state together with necessary and sufficient
criteria for its existence are provided in ref. [62]. The same applies to the
semi-trivial equilibria.
4.2 Results
Numerical simulations show that if only one parameter differs from its ref-
erence value, no Hopf-bifurcation is observed. The same holds if two pa-
rameters differ from their reference values. The minimal requirement for
a Hopf-bifurcation to occur is that three parameters deviate from their re-
spective reference values. All scenarios where Hopf bifurcation can occur
are summarized in Table 2, more details are provided in Appendix B and
Figure 5. For some parameters significant deviations from the reference val-
ues are required to observe Hopf bifurcation. One example for this is the
neutrophil apoptosis rate, where a reduction to less than 25% of its original
value is required. Taking into account the large variations of the respective
cell parameters observed in healthy individuals under immune stimulation
(5-10 fold), parameter changes of this order of magnitude can be considered
biologically realistic [43].
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Our findings are in line with the following results from literature:
1. The fact that Hopf bifurcations only occur if multiple parameters deviate
from their reference values may explain why oscillating blood cell counts
are rarely observed.
2. The death rates of immature cells are increased in most parameter config-
urations. This is in line with experimental findings [22]. However, increase
of immature cell death is not necessary to obtain a Hopf bifurcation (see
Constellations 1 and 2 in Table 2).
3. The model can reproduce neutrophil dynamics in cyclical neutropenia, see
Fig. 4, if the feedback parameter k deviates from its reference value.
4. For certain parameter values the model shows oscillations with a period
of several months. Such oscillations have been observed in case of chronic
myeloid leukemia [18,28,56].
5. Many parameter configurations show increased death rates of stem and/or
progenitor cells. This finding can explain why in some patients oscillations
are induced by chemotherapeutic agents and other drugs inducing cell
death [2, 33, 52].
The numerical studies provide the following insights into diseases with
oscillating blood cell counts.
1. In some parameter configurations a1 or p1 or both are increased. Several
studies show that increased stem cell self-renewal and proliferation are
linked to malignancy [32, 34, 57, 58, 69]. This may explain why oscillating
blood cell counts can be interpreted as a premalignant state [15,42]. How-
ever, increased stem cell self-renewal and proliferation are not necessary
for a Hopf-bifurcation to occur. This may explain why several studies
do not see a relation between oscillating blood cell counts and malignan-
cies [13].
2. According to the considered model Hopf bifurcations can occur for de-
creased mature cell clearance d3 but not for increased d3. This is sur-
prising, since for a long time increased mature cell death has been sus-
pected as the origin of oscillating blood cell counts. Experiments, however,
have shown that mature cell clearance is not increased in cyclic neutrope-
nia [23]. In some patients with cyclic neutropenia a slight decrease of
neutrophil clearance has been reported [23].
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3. Periodic auto-inflammatory syndromes, such as the PFAPA syndrome are
associated with reduced neutrophil apoptosis [37, 66]. These syndromes
are characterized by periodic inflammations with increased white blood
cell counts [5]. Our results support the idea that decreased neutrophil
apoptosis may contribute to the periodicity of the symptoms.
4. All detected parameter configurations involve changes in progenitor or
mature cell parameters compared to healthy controls. It is controversial
whether oscillating blood cell counts require functional deficits on the level
of stem cells or whether alterations in the progenitor cell compartment
are sufficient. Our model suggests that both scenarios can exist. In some
cases stem cell properties (a1, p1, d1) differ from their physiologic reference
values (Constellations 1-5 and 8, 9), whereas in other cases they do not
(Constellations 6 and 7).
5. Whenever a Hopf bifurcation occurs, the counts of stem, progenitor and
mature cells oscillate. This is in line with bone marrow examinations
showing oscillations of immature cells [23]. Furthermore it fits to the
clinical observation that in many patients not only white but also other
blood cell counts oscillate [23, 39]. Of note the observation of oscillating
stem cell counts does not imply that stem cell parameters have to deviate
from their reference values. Alterations of progenitor cell parameters can
be sufficient (Constellations 6 and 7).
6. For many parameter configurations blood cell counts oscillate within phys-
iological bounds. This may suggest that oscillating blood cell counts not
necessarily lead to clinical symptoms. The occurrence of oscillating blood
cell counts in healthy patients is so far controversial [12, 13,51].
7. If the value of k remains unchanged, all considered parameter configura-
tions lead to neutrophil counts that are too high to be compatible with
those observed in cyclic neutropenia [13]. However, changes in the param-
eter k lead to the clinical observed low neutrophil counts. Examples are
depicted in Figure 4. This observation is in line with the experimental
finding that response of immature cells to feedback signals is altered in
patients with cyclic neutropenia [24]. To observe low neutrophil counts
k has to be higher than its reference value. This means that the effect
of cytokines is reduced in patients with cyclic neutropenia, as it has been
observed experimentally [24].
8. The bifurcation point is independent of the value of the feedback param-
eter k. This means that changes in the feedback signal that affect all cells
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Constellation a1 p1 d1 a2 p2 d2 d3
1 ↑ ↓ ↓
2 ↑ ↑ ↓
3 ↑ ↑ ↑
4 ↑ ↓ ↑
5 ↑ ↑ ↓
6 ↑ ↓ ↑
7 ↓ ↑ ↓
8 ↑ ↑ ↑
9 ↑ ↑ ↑
Table 2: Parameter configurations leading to a Hopf bifurcation
simultaneously cannot produce oscillations. Consequently, substitution of
feedback signals (such as G-CSF) cannot prevent oscillations. This is in
line with clinical observations [25]. This finding supports the idea that
alterations in the feedback mechanism may be responsible for the low
neutrophil counts in cyclic neutropenia but not for the oscillations.
5 Discussion
In this work we prove the occurrence of Hopf bifurcation in a mathematical
model of white blood cell formation. The model describes time evolution
of a cell population structured by three maturation stages (stem, progenitor
and mature cells) that are regulated by a nonlinear feedback mechanism. We
show that for appropriate parameter choices a super-critical Hopf bifurcation
occurs and a stable limit cycle emerges. This constitutes a major difference
to the two-compartment version of the model that distinguishes only between
mature and immature cells and has a globally stable steady state [20]. This
finding demonstrates that the number of maturation stages can impact dy-
namical features of the system.
The considered model has been applied to clinical data and shows a good
agreement with reality [47, 57–61]. It predicts that a Hopf bifurcation can
occur for biologically plausible parameters and thus provides possible expla-
nations for disease mechanisms that lead to oscillating blood cell counts. Our
systematic numerical study suggests that sustained oscillations only occur if
multiple parameters deviate from their physiological reference values. This
finding is in line with the observation that oscillating blood cell counts are
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rarely observed.
Biological data and theoretical results have linked the occurrence of os-
cillating blood cell counts to increased death rates of immature cells. This
finding is supported by our model, however, our results suggest that in-
creased immature cell death is not necessary to obtain a stable limit cycle.
Alterations of mature cell death rates together with stem or progenitor cell
self-renewal and proliferation are also sufficient. The impact of perturbed
self-renewal on oscillating blood cell counts has been discussed in the con-
text of a linear model [16].
One of the most common diseases exhibiting periodic oscillations of white
blood cells it cyclic neutropenia. Our model suggests that the low cell num-
bers detected in these patients can only be reproduced if the response of
immature cells to feedback signals is reduced. This result is in line with in
vitro experimental findings. Interestingly, the occurrence of Hopf-bifurcation
is independent of the parameters that describe the feedback signal. This sug-
gests that alterations in the feedback that simultaneously affect all cell types
cannot lead to oscillating cell counts. However, in presence of parameter con-
figurations that lead to oscillations, an additional alteration of the feedback
signal can impact their amplitude. This result leads to the hypothesis that
the experimentally detected reduced response of immature cells to cytokines
in patients with cyclic neutropenia is the pathogenic mechanism leading to
low cell counts; however it does not contribute to the occurrence of oscil-
lations. This hypothesis is further supported by clinical data showing that
administration of growth factors such as G-CSF increases white blood cell
counts but does not lead to cessation of the periodic oscillations [25,49].
The finding that multiple different parameter configurations can result in
oscillating blood cell counts may explain parts of the heterogeneity among
cyclic neutropenia patients. It furthermore suggests that different detected
mutations [1,4,8,19,45,71] may lead to different pathogenic mechanisms that
result in similar symptoms.
In summary, we have proven the occurrence of a Hopf bifurcation in a
non-linear three-compartment model of white blood cell formation. The Hopf
bifurcation is a unique feature of the three-compartment setting and does not
occur in the 2-compartment version of the model. We identify biologically
plausible parameter sets that lead to a stable limit cycle and relate them
to clinical and experimental findings. This quantitative approach can help
to understand the pathogenic mechanisms and the clinical heterogeneity of
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different diseases that lead to oscillating blood cell counts.
A Supplementary calculations to the proof of
Theorem 4
In the following we provide the calculations leading to equation (3).
b1 b2 − b3
=
[(
1− a2
a1
)
p2 +
(
1− a2
a1
(
1− 1
2 a1
)
1
2− a2
a1
)
d3
]
·
[(
1− a2
a1
) (
1− a2
a1
(
1− 1
2 a1
)
1
2− a2
a1
)
−
(
1− 1
2 a1
) (
1− 2 a2
a1
)]
d3 p2
−
(
1− 1
2 a1
) (
1− a2
a1
)
d3 p2
=
[(
1− a2
a1
)
p2 +
(
1− a2
a1
(
1− 1
2 a1
)
1
2− a2
a1
)
d3
]
·
(
1− 1
2 a1
) (
1− a2
a1
) [
1
1− 1
2 a1
− a2
a1
1
2− a2
a1
− 1− 2
a2
a1
1− a2
a1
]
d3 p2
−
(
1− 1
2 a1
) (
1− a2
a1
)
d3 p2
=
(
1− 1
2 a1
) (
1− a2
a1
) ([(
1− a2
a1
)
p2 +
(
1− a2
a1
(
1− 1
2 a1
)
1
2− a2
a1
)
d3
]
·
 1
2 a1
1
1− 1
2 a1
+
a2
a1
1(
2− a2
a1
) (
1− a2
a1
)
− 1
 d3 p2
=
(
1− 1
2 a1
) (
1− a2
a1
) ([(
1− a2
a1
)
p2 + β (a1, a2) d3
]
· γ (a1, a2)− 1
)
d3 p2.
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B Parameter configurations leading to Hopf
bifurcation
Constellation 1:
p1 increased
a2 decreased
d3 decreased (< 0.5/day)
Example:
p1 = 0.7171/day
a2 = 0.32
d3 = 0.132/day
Constellation 2:
p1 increased
a1 increased
d3 decreased (close to 0.1/day)
Example:
p1 = 0.9697/day
a1 = 0.99
d3 = 0.132/day
Constellation 3:
p1 increased
a2 increased (close to 1)
d2 increased
Example:
p1 = 0.7778/day
a2 = 0.99
d2 = 2.6644/day
Constellation 4:
p1 increased
p2 decreased
d2 increased
Example:
p1 = 0.8687/day
p2 = 0.0201/day
d2 = 0.2541/day
Constellation 5:
p1 increased
d2 increased
d3 decreased
Example:
p1 = 0.707/day
d2 = 0.2541/day
d3 = 0.132/day
Constellation 6:
p2 decreased (close to 0.01)
a2 increased (close to 1)
d2 increased
Example:
p2 = 0.01/day
a2 = 0.99
d2 = 0.5287/day
26
Constellation 7:
p2 decreased
d2 increased
d3 decreased
Example:
p2 = 0.01/day
d2 = 0.0405/day
d3 = 0.132/day
Constellation 8:
a1 increased
d1 slightly increased (< 0.1/day)
d2 increased
Example:
a1 = 0.95
d1 = 0.0405/day
d2 = 2.7559/day
Constellation 9:
a2 increased
d1 slightly increased (< 0.05/day)
d2 increased
Example:
a2 = 0.95
d1 = 0.0405/day
d2 = 2.5423/day
Biologically plausible parameter regions where the Hopf-bifurcation exists are
visualized in Figure 5. The reported values for a1 and a2 correspond to the
self-renewal fraction in presence of maximal stimulation. The self-renewal
fraction at time t is given by a1s(t) and a2s(t) with s(t) < 1.
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